Showing results (851-860 of 1,192) with videos related to
Sort By:
Pageof 120
Plos One|March 11, 2011
"Dynamic range" of inferred phenotypic HIV drug resistance values in clinical practiceLuke C Swenson, Graham Pollock, Brian Wynhoven, et al.Biochemistry|May 25, 2012
Orotidine 5'-monophosphate decarboxylase: transition state stabilization from remote protein-phosphodianion interactionsTina L Amyes, Shonoi A Ming, Lawrence M Goldman, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|March 17, 1999
[Diabetic coronary disease and risk of myocardial infarction]P Henry, P Richard, F Beverelli, et al.AIDS (London, England)|April 20, 2004
Are untimed antiretroviral drug levels useful predictors of adherence behavior?Cheryl A Liechty, Christopher S Alexander, P Richard Harrigan, et al.Obstetrics and Gynecology|August 11, 2017
Human Immunodeficiency Virus Viral Load Rebound Near Delivery in Previously Suppressed, Combination Antiretroviral Therapy-Treated Pregnant WomenIsabelle Boucoiran, Arianne Y K Albert, Karen Tulloch, et al.Journal of the International AIDS Society|September 28, 2017
A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015Michelle Olding, Ben Enns, Dimitra Panagiotoglou, et al.The European Journal of Neuroscience|April 10, 2010
Antidepressant fluoxetine suppresses neuronal growth from both vertebrate and invertebrate neurons and perturbs synapse formation between Lymnaea neuronsFenglian Xu, Collin Luk, Maria P Richard, et al.European Journal of Orthodontics|April 6, 2017
Impact of adenotonsillectomy on the dentofacial development of obstructed children: a systematic review and meta-analysisBibi E Becking, Jop P Verweij, Sonja M Kalf-Scholte, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence levelViviane D Lima, David R Bangsberg, P Richard Harrigan, et al.Acta Neurochirurgica. Supplement|May 9, 2013
Active stimulation site of nucleus accumbens deep brain stimulation in obsessive-compulsive disorder is localized in the ventral internal capsulePepijn van den Munckhof, D Andries Bosch, Mariska H M Mantione, et al.Pageof 120